Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Study on the Promotion of hADSCs Migration and Chemotaxis by SDF-1.

Jin C., Xu G.

Laboratory Study, published in Asia Pac J Ophthalmol (Phila) (2023) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Asia Pac J Ophthalmol (Phila) (2023)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
37171133
DOI
10.1097/APO.0000000000000613

Abstract (original English)

Purpose The purpose of this study was to investigate the chemotaxis effect of stromal cell-derived factor-1 (SDF-1) on human adipose-derived stem cells (hADSCs). Methods A lentivirus vector with the enhanced green fluorescent protein gene was constructed and transfected to hADSCs. A control group and an SDF-1 induction group were set to estimate the efficacy of SDF-1 in promoting hADSCs chemotaxis and migration. Results After 7 days of infection with hADSCs by enhanced green fluorescent protein lentivirus, the positive rate of fluorescence expression detected by flow cytometry was 100%. After the addition of SDF-1 induction, the invasion ability of hADSCs was enhanced. Conclusions SDF-1 can promote hADSCs migration and chemotaxis, which may play a role in stem cell transplantation.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
HumansChemotaxisStem Cell TransplantationChemokine CXCL12

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.